Amgen Boosts FY23 Adj EPS Outlook From $17.60-$18.70 To $17.80-$18.80, Consensus $17.75
Portfolio Pulse from Benzinga Newsdesk
Amgen has increased its FY23 adjusted EPS outlook from $17.60-$18.70 to $17.80-$18.80, surpassing the consensus estimate of $17.75.
August 04, 2023 | 2:34 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Amgen's raised FY23 adjusted EPS outlook, which surpasses consensus estimates, could positively impact its stock price.
Amgen's raised EPS outlook for FY23, which is higher than the consensus estimate, indicates strong future performance. This could increase investor confidence and demand for the stock, potentially driving its price up.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100